Navigation Links
Frost & Sullivan Awards Baxter's BioPharma Solutions Business the 2008 North American Customer Service Leadership of the Year Award
Date:11/13/2008

BPS Named Contract Manufacturer of Choice, Based on Its Comprehensive Service Portfolio

MOUNTAIN VIEW, Calif., Nov. 13 /PRNewswire/ -- Based on its recent analysis of the pharmaceutical contract manufacturing market, Frost & Sullivan has awarded Baxter's BioPharma Solutions (BPS) with the 2008 North American Frost & Sullivan Customer Service Leadership of the Year Award at the 2008 Excellence in Healthcare Innovation Awards Banquet held in San Antonio, Texas, on Wednesday, November 12, 2008. BPS was recognized for its dedication to providing a wide portfolio of services, strong customer focus, and high customer satisfaction ratings.

"BPS is considered the top choice for outsourcing of manufacturing by respondents from the pharmaceutical and biotechnology industry surveyed in the 2008 Frost & Sullivan Voice of the Customer analysis," says Frost & Sullivan Research Analyst Barath Shankar Subramanian. "BPS is one of the leading contract manufacturing organizations (CMOs) in the sterile manufacturing market -- especially pre-filled syringes and lyophilized vials."

The foundation of BPS' success is its customer-centric service model, Process 360, which offers customers a true partnership experience. It creates transparency and access to the complex process of bringing a molecule to market -- and focuses on scientific expertise, market-differentiating technology, highly-involved customer service, high-quality, reliable supply and bottom-line results.

BPS' robust customer-focused approach ensures constant evaluation of customer needs and satisfaction to make certain the company delivers quality services at all times. It also maintains multiple channels of communication with its clients to facilitate continuous engagement and flow of information with clients.

"In addition to providing contract manufacturing services, BPS also offers upstream and downstream services, such as formulation services, development services and packaging,"
'/>"/>

SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Transport Pharmaceuticals Receives Coveted Frost & Sullivan Technology Innovation Award
2. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
3. Digirad Corporation to Receive Frost & Sullivan 2007 North American Award for Product Strategy
4. Signalife Wins Second Frost & Sullivan Technology Award
5. AdvanDx Receives Frost & Sullivans Rapid In-Vitro Diagnostic Technology Innovation of the Year Award
6. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
7. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
8. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
9. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
10. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
11. Frost & Sullivan Recognizes Kionixs Dominance in the MEMS Accelerometers Market Through Product Line Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... NEW YORK , May 4, 2015 /PRNewswire-USNewswire/ ... system for granted. But for certain infants with ... and death are stark consequences of their impaired ... Langone Medical Center have identified an important role ... infection resulting from Mycobacterium tuberculosis, the bacterium causing ...
(Date:5/4/2015)... JSS Medical Research Inc., a Montreal based ... of Max Neeman International (MNI), with head office in ... Ahmedabad, Bangalore , Chennai ... regional office is located North Carolina, USA . ... equity investment transaction into JSS with Capital Croissance PME (CCPME), a ...
(Date:5/4/2015)... BOSTON , May 4, 2015 ... development of novel therapies for neurological and neuropsychiatric ... has initiated dosing of Alzheimer,s patients in a ... candidate, GC021109, a compound developed as a potential ... disease is innovative in that it both promotes ...
(Date:5/4/2015)... 4, 2015  Traverse Biosciences announced today that ... development agreement (CRADA) with Aratana Therapeutics Inc. (NASDAQ: ... TRB-N0224 for the treatment and control of periodontal ... Traverse Biosciences has also granted Aratana an exclusive ... control of periodontal disease in companion animals, inclusive ...
Breaking Biology Technology:Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 3JSS Medical Canada widens its global presence across Asia/Pacific region 2JSS Medical Canada widens its global presence across Asia/Pacific region 3JSS Medical Canada widens its global presence across Asia/Pacific region 4GliaCure Initiates Phase 1b Dosing in Alzheimer's Patients 2Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 2Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 3Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 4
... Jan. 28 Bion Environmental Technologies, ... on Monday, January 26, 2009, the Pennsylvania Infrastructure ... to Bion PA 1, LLC (a wholly-owned subsidiary ... the loan will be used to construct Bion,s ...
... quarter EPS of $0.44 -- increase of 110% from prior year ... Corporation (Nasdaq: KNSY ), a leading medical technology company ... medical procedures, today reported the results for its second quarter and ... , Record ...
... , - Guests Will Bounce ... Staying healthy in these stressful times ... Health Retreats early in 2009 may provide,participants with the impetus ... A key component of the retreat will ...
Cached Biology Technology:Bion Announces PENNVEST Board Approves $7.8 Million Financing for Kreider Farms Dairy Project 2Bion Announces PENNVEST Board Approves $7.8 Million Financing for Kreider Farms Dairy Project 3Bion Announces PENNVEST Board Approves $7.8 Million Financing for Kreider Farms Dairy Project 4Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 2Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 3Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 4Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 5Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 6Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 7Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 8Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 9Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 10Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 11Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 12Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 13Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 14Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 15Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 16Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 17Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 18New Health Retreat Gives a Fresh Attitude Towards Disease Prevention 2
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ) has ... - NEC" report to their offering. ... to supply a range of IT security management and ... on the development of a Big Data and cloud ... Asia-Pacific region is a core ...
(Date:4/2/2015)... At its 2015 ACMG Annual Clinical Genetics ... the American College of Medical Genetics and Genomics (ACMG) ... Board.  Members of the ACMG Board of Directors serve ... advancing its policies and programs. ACMG is the national ... an eventful time in medical genetics and genomics.  We ...
(Date:3/31/2015)... 2015  Elephant Talk Communications Corp. (NYSE MKT: ETAK) ... Software Defined Network Architecture (ET Software DNA® 2.0) platforms ... approximately $20.4 million for the year ended December 31, ... the year ended December 31, 2013. ... completed its multi-year transition away from its legacy landline ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... are reporting that a technique used in the search for ... discover new, environmentally friendly materials for fighting global warming. Such ... dioxide from industrial smokestacks and other fixed sources before it ... journal Energy & Fuels . Michael Drummond and ...
... an advance with overtones of Star Trek phasers and other ... an internal on-off "switch" that paralyzes animals when exposed to ... when the light is turned off. When exposed to ordinary ... appears in the Journal of the American Chemical Society ...
... of Pennsylvania studying oocytes in mice, the immature egg ... behavior in microRNA, or miRNA, activity that may be ... pluripotent blastomeres of the embryo. MicroRNAs are a member ... matter of the biological world. MicroRNAs imperfectly pair ...
Cached Biology News:Penn biologists determine microRNA activity is suppressed in mouse ovum 2
... Source: Crotalus adamanteus venom Description: ... widely used in studying nucleic ... . It hydrolyzes 5'-mononucleotides from ... . Phosphodiesterase I cleaves ADP-ribosylated ...
Economical and manually filled LN2 vacuum insulated storage container offers high capacity and low nitrogen consumption while offering convenient storage of samples....
... digitonin and digoxin. Physical form: Lyophilized powder containing ... 0.06% NaCl Preparation Note: Sodium iodide extracted fraction ... 19, 755 (1965). Unit Definition: One unit ... ATP per min at pH 7.4 at 37 ...
... introduced the highly potent TURBO DNase (patent pending) ... was set in DNA removal capabilities. TURBO DNase ... that is much more efficient than wild type ... unwanted DNA. TURBO DNase binds DNA substrates 6-fold ...
Biology Products: